Crossmark

Fixed-dose Combination of Metoprolol, Telmisartan, and Chlorthalidone for Essential Hypertension in Adults with Stable Coronary Artery Disease: Phase III Study

Crossref DOI link: https://doi.org/10.1007/s12325-021-01971-9

Published Online: 2021-12-17

Published Print: 2022-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Sarkar, Gouranga

Gaikwad, Vijay B.

Sharma, Aradhana

Halder, Swapan K.

Kumar, Darivemula A.

Anand, Jitendra

Agrawal, Sumit

Kumbhar, Avinash

Kinholkar, Bhushan

Mathur, Rishabh

Doshi, Maulik

Bachani, Deepak

Mehta, Suyog
Clinical Trials ^BETA

Clinical trials referenced in this document:

ctri/2016/11/007491 at Clinical Trials Registry India

Documents that mention this clinical trial
Funding

Funding for this research was provided by:

Sun Health Foundation
License Information

Text and Data Mining valid from 2021-12-17

Version of Record valid from 2021-12-17
More Information

Article History

Received: 20 July 2021

Accepted: 19 October 2021

First Online: 17 December 2021

Document is current

Any future updates will be listed below